1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial results from first-in-human study of IPI-549, a tumor macrophage-targeting agent, combined with nivolumab in advanced solid tumors
    Meeting Abstract

    Sullivan, R. J.; Hong, D. S.; Tolcher, A. W.; Patnaik, A.; Shapiro, G.; Chmielowski, B.; Ribas, A.; Brail, L. H.; Roberts, J.; Lee, L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Exploring effects of MEK inhibition in tumor microenvironment in non-small cell lung cancer (NSCLC) pre-clinical models
    Meeting Abstract

    Silk, T.; Choi, H.; Deng, J.; Pourpe, S.; Wong, K. K.; Merghoub, T.; Wolchok, J. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Indirect treatment comparison of nivolumab versus placebo as an adjuvant therapy for resected melanoma
    Meeting Abstract

    Shoushtari, A. N.; Freeman, M. L.; Betts, K. A.; Gupte-Singh, K.; Du, E. X.; Ritchings, C.; Rao, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutational burden, clinical features, and outcomes to PD-1 mono- and combination therapy in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Shoushtari, A. N.; Armenia, J.; Arora, A.; Rojas-Zamalloa, J.; Warner, A. B.; Derr, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Coit, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade
    Meeting Abstract

    Santomasso, B.; Haggiagi, A.; Malani, R.; Maher, C. A.; Holder, J. N.; Shames, Y.; Wilcox, J.; Flynn, J.; Briggs, S.; Panageas, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Anti-CD27 agonist antibody varlilumab (varli) with nivolumab (nivo) for colorectal (CRC) and ovarian (OVA) cancer: Phase (Ph) 1/2 clinical trial results
    Meeting Abstract

    Sanborn, R. E.; Pishvaian, M. J.; Callahan, M. K.; Weise, A. M.; Sikic, B. I.; Rahma, O. E.; Cho, D. C.; Rizvi, N. A.; Bitting, R. L.; Starodub, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who have received PD-1 based therapy
    Meeting Abstract

    Saab, K.; Mooradian, M.; Wang, D. Y.; Chon, J.; Xia, C. Y.; Bialczak, A.; Abbate, K.; Menzies, A. M.; Johnson, D. B.; Sullivan, R. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma
    Meeting Abstract

    Postow, M. A.; Knox, S. J.; Goldman, D.; Panageas, K.; Halpenny, D.; McCabe, D.; Macri, M. J.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody (Mb) 89Zr-IAB22M2C, in advanced solid tumors
    Meeting Abstract

    Postow, M. A.; Harding, J. J.; Hellmann, M. D.; Gordon, M. S.; Tsai, F.; Donoghue, J. A. O.; Lewis, J. S.; Wu, A. M.; Le, W.; Korn, R. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1
    Meeting Abstract

    McQuade, J. L.; Warner, A. B.; Li, M. M.; Chon, J.; Haydu, L. E.; Daniel-MacDougall, C.; Hess, K. R.; Johnson, D. B.; Menzies, A. M.; Davies, M. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save